Shanghai Institute of Biological Products-Shanghai Jiehao Biotechnology Co., Ltd. and CLP 4 Co.

Shanghai jiehao biotechnology co., ltd. and CLP 4 co., ltd. join hands to build advanced clean room of Shanghai institute of biological products

Project Background

Shanghai jiehao biotechnology co., ltd (hereinafter referred to"Jie Hao Biology") Join hands with China Electronic System Engineering Fourth Construction Co., Ltd. (hereinafter referred to"CLP IV"), for the Shanghai Institute of Biological Products (hereinafter referred to"Shangsheng Institute") Provide a series of laboratory equipment including laminar flow hood, laminar flow bay, transfer window, steel door, interlock control system, stainless steel rail, etc. As a leading comprehensive service provider of high-tech industrial engineering in China, CLP IV has rich experience in the field of biomedical construction, has served a number of well-known enterprises at home and abroad, showing its strong strength in this field.

Shangsheng Institute

Shangsheng Institute is an important research institution under China Biotechnology Co., Ltd. Since its establishment, it has been the main research institution of national medical microbiology, immunology, cell engineering, genetic engineering, and blood products. Shangsheng Institute has not only developed a variety of vaccines, such as live attenuated varicella vaccine, influenza virus split vaccine, etc., but also won a number of honors and recognition, and its products enjoy a high reputation in China

CLP IV

CLP IV has a significant industry position in the field of biomedical construction, and its engineering construction market share is ahead of that of domestic pharmaceutical companies.20name50%, and at a high levelP3animal biosafety laboratory engineering construction market occupies more50%. CLP IV has provided services to well-known domestic and foreign companies such as Pfizer, AstraZeneca, Qilu, Merck, Roche, Novartis, etc., proving its leading position in the industry.

Jie Hao

In this cooperation, Shanghai Jiehao Biotechnology Co., Ltd. and China Electronics System Engineering Fourth Construction Co., Ltd. provided the Shanghai Institute of Biological Products.clean room equipmentspecifically include:

1. laminar flow hood: This is an air filtration device that provides sterile air to the work area through a high-efficiency filtration system to ensure that the air quality in the laboratory meets biosafety requirements.
2. inter-laminar flow: Also known as a clean room, it is a closed space equipped with air filtration and control systems to maintain cleanliness in a specific area, suitable for experimental operations with high cleanliness requirements.
3. transmission window: This is a special airtight chamber used to transfer items between areas of different cleanliness levels while preventing the spread of pollutants.
4. steel door: These doors have high strength and durability, and are usually used for the entrance and exit of the laboratory to maintain the tightness and safety of the laboratory.
5. interlock control system: This is a safety system used to control the opening and closing of different doors in the laboratory to ensure that no more than one door is opened at the same time, thereby avoiding cross-contamination.
6. stainless steel railing: These railings are used in or around the laboratory to provide additional safety precautions to prevent accidental falls or contact with hazardous areas.

(need to know more products, please contact us)

cooperation

Through the cooperation with the four companies of china power, jiehao biological has provided a comprehensive biosafety laboratory equipment solution for the institute. The introduction of these equipment not only improves the safety and operation efficiency of the laboratory, but also creates a good environment for the scientific research work of the Institute. Jiehao biological equipment provides a solid foundation for the scientific research projects of the Institute and supports the research and development of a number of biological products.

Customer Feedback

Shangsheng Institute spoke highly of the products and services of Jie Hao Biology and CLP No.4 Company. Jiehao Bio has demonstrated its leading technology and rich experience in the development and production of biosafety equipment, while CLP IV has ensured the smooth implementation of the project with its professional engineering construction capabilities. Customers say that the installation and use of these devices have greatly improved the efficiency and safety of the laboratory.

This cooperation fully demonstrates the professional ability and market competitiveness of Jiehao Bio in the field of biosafety, and also highlights the leading position of CLP IV in the field of domestic biomedical construction. Jiehao biological will continue to provide high-quality products and services for more biological products research institutions, and promote the sustainable development of biosafety. At the same time, CLP IV will also provide high-quality engineering services to more enterprises with its professional strength in the field of high-tech industrial engineering, and jointly promote the prosperity and development of the biomedical industry.

Shanghai Institute of Biological Products is an important research institution under China Biotechnology Co., Ltd., established in September 1949, is an important research and application institution in the fields of medical microbiology, immunology, cell engineering, genetic engineering and so on. The institute integrates the research and development, production, sales and personnel training of biological products, and is a master's degree awarding unit of biochemistry, molecular biology and pathogenic biology approved by the state.

Shanghai Institute of Biological Products has rich R & D and production experience in the field of biological products, including blood products, preventive products, genetic engineering products and various diagnostic reagents. The institute has an advanced blood preparation production line and a vaccine production building that meets the EU GMP standards. All production workshops have passed the national GMP certification. In addition, the institute has also successfully developed a variety of vaccines, such as live attenuated varicella vaccine, influenza split vaccine, etc., and has achieved a good reputation in the domestic and foreign markets.

Recently, the Shanghai Institute of Biological Products has made significant progress in vaccine research and development. On September 9, 2024, the MVA strain live attenuated monkeypox vaccine independently developed by the institute received a clinical trial notice issued by the State Drug Administration, becoming my country's first clinically approved monkeypox vaccine. This progress marks an important step forward in the Institute's response to the prevention and control of the disease caused by monkeypox virus. The vaccine was developed based on the replication-deficient vaccinia virus MVA strain, and its safety and efficacy are well supported by clinical data. The vaccine uses a mature cell factory production process to ensure the stability of the process and the reliability of quality. Preclinical studies have shown that the vaccine can produce good immune protection against monkeypox virus challenge in non-human primate models.

Shanghai Institute of Biological Products not only demonstrate its professional strength in the field of biological products, but also reflect its important contribution to national public health security. With the advancement of clinical research on monkeypox vaccine, the institute is expected to provide more support and help for the prevention and control of the global monkeypox epidemic.

https://www.siobp.com/

China Electronic System Engineering Fourth Construction Co., Ltd. (referred to as "CLP Fourth Company") was established in 1953 and is affiliated to China System (CESTC) under China Electronics (CEC), one of the world's top 500 companies. It is a company focusing on high-tech industrial engineering Comprehensive service provider in the field. The company's business covers engineering consulting, engineering design, engineering contracting, facility management and product manufacturing, especially in high-tech fields such as semiconductors, flat panel displays, biomedicine, chemical environmental protection, cloud computing and new energy.

CLP No. 4 Company enjoys a good social reputation at home and abroad, and has won many honors such as Luban Award, National Quality Engineering Award, China Installation Star, etc., and has been rated as "National Excellent Construction Enterprise" and "National AAA Credit Enterprise". The company attaches great importance to scientific and technological innovation, has a wealth of patents and standards, as well as a strong professional and technical team.

In the field of biomedical construction, CLP IV has demonstrated its strong strength and professional capabilities. The company has built and served projects of Pfizer, AstraZeneca, Qilu, Merck, Roche, Novartis and other well-known enterprises at home and abroad, reflecting its leading position and influence in the industry. In addition, CLP IV also actively participated in major national strategic projects, such as the construction of nearly 20 new coronary pneumonia vaccine production workshops for enterprises such as Beisheng Institute, Wusheng Institute, Beijing Kexing and Zhifei Bio during the new coronary pneumonia epidemic, making important contributions to the global fight against the epidemic.

CLP Fourth Company takes "domestic first-class engineering company" as its vision, adhering to the values of "truth-seeking, integrity, harmony, and diligence" and the business philosophy of "customer-oriented, service-leading", and is committed to providing customers with high-quality engineering services. Contribute more high-quality projects to the society, and make new and greater contributions to the prosperity and development of high-tech industries.

http://www.cefoc.cn/